NCT04926116View on ClinicalTrials.gov

A Study of AK3280 in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

September 28, 2021

Study Completion Date

September 28, 2021

Conditions
Healthy
Interventions
DRUG

AK3280

Active Substance: AK3280, Pharmaceutical Form: Tablet, Route of Administration: Oral

DRUG

Placebo

Active Substance: Placebo, Pharmaceutical Form: Tablet, Route of Administration: Oral

Trial Locations (1)

100029

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

Shanghai Ark Biopharmaceutical Co., Ltd.

INDUSTRY